Cellectar Biosciences Inc... (CLRB)
NASDAQ: CLRB
· Real-Time Price · USD
4.37
-0.05 (-1.13%)
At close: Aug 15, 2025, 3:59 PM
4.41
0.92%
After-hours: Aug 15, 2025, 07:05 PM EDT
Cellectar Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -9.7M | -6.6M | -2.36M | -14.66M | -5.98M | -21.58M | -7.88M | -13.73M | -8.22M | -8.58M | -7.22M | -7.81M | -7.44M | -6.14M | -5.92M | -5.82M | -6.03M | -6.36M |
Depreciation & Amortization | 43.29K | 56.29K | 68.57K | 68.57K | 66.02K | 88.49K | 69.96K | 41.21K | 38.65K | 42.56K | 38.16K | 32.96K | 33.9K | 43.42K | 39.29K | 36.79K | 38.7K | 35.13K |
Stock-Based Compensation | -356.99K | n/a | 1.49M | 1.53M | 799.25K | 454.36K | 1.08M | 497.88K | 419.76 | 408.21 | 361.45 | 367.76 | 419.95K | 303.81K | 377.85K | 421.16K | 200.62K | 124.56K |
Other Working Capital | 63.56K | -45.48 | 655.41K | 382.53K | -716.76K | -453.6K | 219.21K | -682.27K | 731.76K | -1.43M | -2.24M | -530.36K | 247.5K | 74.63K | 557.67K | -731.21K | 398.44K | -29.15K |
Other Non-Cash Items | 20.86M | 6.54M | -10.05M | 1.67M | -7.38M | 9.92M | -82.25K | 14.73K | 14.21K | 13.83K | 23.89K | 23.01K | 25.56K | 21.36K | 20.56K | 19.79K | 19.05K | 18.32K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -4.37M | 4.37M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.94K |
Change in Working Capital | 63.56K | -45.48 | -63.56K | 2.22M | -1.65M | -2.24M | 1.58M | 740.64K | 218.89K | 933K | -620.16K | 374.41K | 1.2M | 731.43K | 969.39K | -1.09M | -1.11M | 1.42M |
Operating Cash Flow | 10.91M | -9.38K | -10.91M | -9.17M | -14.14M | -13.36M | -9.6M | -8.07M | -7.53M | -7.18M | -7.41M | -7.01M | -5.76M | -5.04M | -4.51M | -6.43M | -6.88M | -4.75M |
Capital Expenditures | 61.29K | n/a | -61.29K | 3.00 | -21.28K | -21.63K | -266.76K | -597.28K | n/a | n/a | -117.86K | -7.07K | -70.98K | -30.07K | -129.74K | -4.06K | -7.56K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 61.29K | n/a | -61.29K | n/a | -21.28K | -21.63K | -266.76K | -597.28K | n/a | n/a | -117.86K | -7.07K | -70.98K | -30.07K | -129.74K | -4.06K | -7.56K | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.00 | n/a | n/a | n/a | n/a | n/a | n/a | 34.87K | 1.21M |
Financial Cash Flow | 2.25M | n/a | n/a | 17.56M | n/a | 43.85M | 441K | 22.5M | n/a | 3.00 | 9.61M | n/a | n/a | n/a | n/a | n/a | 34.87K | 1.21M |
Net Cash Flow | -12.25M | -9.38K | -10.97M | 8.39M | -14.16M | 30.47M | -9.42M | 13.83M | -7.53M | -7.18M | 2.08M | -7.02M | -5.83M | -5.07M | -4.64M | -6.43M | -6.85M | -3.54M |
Free Cash Flow | 10.97M | -9.38K | -10.97M | -9.17M | -14.16M | -13.38M | -9.86M | -8.67M | -7.53M | -7.18M | -7.53M | -7.02M | -5.83M | -5.07M | -4.64M | -6.43M | -6.88M | -4.75M |